| P50 | author | Mihai Netea | Q24517868 |
| | Seyedmojtaba Seyedmousavi | Q40062294 |
| | Willem Melchers | Q56859383 |
| | Paul E. Verweij | Q70514014 |
| P2093 | author name string | G Sybren de Hoog | |
| | Johan W Mouton | |
| P2860 | cites work | Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS | Q22242658 |
| | Melanized Fungi in Human Disease | Q24633163 |
| | Phylogeny of rock-inhabiting fungi related to Dothideomycetes | Q24653570 |
| | The neurotropic black yeast Exophiala dermatitidis has a possible origin in the tropical rain forest | Q24656598 |
| | Cytolocalization of the class V chitin synthase in the yeast, hyphal and sclerotic morphotypes of Wangiella (Exophiala) dermatitidis | Q30373183 |
| | Allergy and dermatophytes | Q30435661 |
| | Phaeohyphomycoses, emerging opportunistic diseases in animals | Q30585034 |
| | Black yeast-like fungi associated with Lethargic Crab Disease (LCD) in the mangrove-land crab, Ucides cordatus (Ocypodidae). | Q31052940 |
| | Molecular analysis and pathogenicity of the Cladophialophora carrionii complex, with the description of a novel species. | Q31155973 |
| | ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi. | Q42230330 |
| | Phagocytosis, production of nitric oxide and pro-inflammatory cytokines by macrophages in the presence of dematiaceous [correction of dematiaceus] fungi that cause chromoblastomycosis. | Q42501321 |
| | Isolation and identification of black yeasts by enrichment on atmospheres of monoaromatic hydrocarbons. | Q42545957 |
| | Murine model of a disseminated infection by the novel fungus Fonsecaea monophora and successful treatment with posaconazole | Q42929693 |
| | Antifungal therapies in murine disseminated phaeohyphomycoses caused by Exophiala species | Q43057932 |
| | Environmental isolation of black yeast-like fungi involved in human infection. | Q43078373 |
| | Exogenous interferon-gamma immunotherapy for invasive fungal infections in kidney transplant patients | Q43114682 |
| | A previously undescribed synanamorph of Wangiella dermatitidis. | Q43516475 |
| | CARD9 mutations linked to subcutaneous phaeohyphomycosis and TH17 cell deficiencies | Q43687259 |
| | Dematiaceous--a mycologic misnomer? | Q43702241 |
| | Fungal keratitis caused by Colletotrichum gloeosporioides. | Q43783634 |
| | Granulomatous reaction and tissue remodelling in the cutaneous lesion of chromomycosis | Q43783717 |
| | Treatment of chronic murine chromoblastomycosis with the triazole SCH39304. | Q43920485 |
| | Subcutaneous phaeohyphomycosis caused by Exophiala jeanselmei in a patient with advanced tuberculosis | Q44128737 |
| | Fungal melanonychia: ungual phaeohyphomycosis caused by Wangiella dermatitidis | Q44228397 |
| | Alternate week and combination itraconazole and terbinafine therapy for chromoblastomycosis caused by Fonsecaea pedrosoi in Brazil | Q44236436 |
| | Cutaneous phaeohyphomycosis caused by Exophiala jeanselmei after renal transplantation. | Q44271724 |
| | Cellular immune response of patients with chromoblastomycosis undergoing antifungal therapy | Q44488896 |
| | Exophiala dermatitidis pneumonia in cystic fibrosis | Q44514457 |
| | Cerebral phaeohyphomycosis in an immunodeficient child treated medically with combination antifungal therapy | Q44578769 |
| | Chronic mucocutaneous candidiasis-thymoma syndrome. A case report | Q44670422 |
| | Differentiation of Fonsecaea pedrosoi mycelial forms into sclerotic cells is induced by platelet-activating factor | Q44672463 |
| | Histopathology and antifungal treatment of experimental murine chromoblastomycosis caused by Cladophialophora carrionii | Q44752247 |
| | Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents. | Q44930550 |
| | Melanogenesis in Cryptococcus neoformans | Q44939936 |
| | Chronic mucocutaneous candidiasis accompanied by enhanced antibody production | Q44966273 |
| | Anti-neutrophil cytoplasmic antibodies in patients with chromomycosis. | Q46014508 |
| | Antifungal susceptibility testing of Exophiala spp.: a head-to-head comparison of amphotericin B, itraconazole, posaconazole and voriconazole | Q46183948 |
| | Combined antifungal therapy in a murine model of disseminated infection by Cladophialophora bantiana | Q46196688 |
| | Molecular epidemiology of Cladosporium carrionii. | Q46667932 |
| | Effect of melanin and carotenoids of Exophiala (Wangiella) dermatitidis on phagocytosis, oxidative burst, and killing by human neutrophils | Q39509139 |
| | Absence of CD4+ T cells impairs host defence of mice infected with Fonsecaea pedrosoi. | Q39515775 |
| | Highly specific and sensitive, immunoblot-detected 54 kDa antigen from Fonsecaea pedrosoi | Q39559642 |
| | Melanins and their importance in pathogenic fungi | Q39644901 |
| | Medical significance of the so-called black yeasts | Q39662720 |
| | Antioxidant function of melanin in black fungi | Q39823830 |
| | Catheter-associated fungemia due to Wangiella (Exophiala) dermatitidis. | Q40010494 |
| | Fatal systemic cladosporiosis in a merino sheep flock | Q40355990 |
| | Developments in hyalohyphomycosis and phaeohyphomycosis. | Q40509567 |
| | Case study: posaconazole treatment of disseminated phaeohyphomycosis due to Exophiala spinifera | Q40542101 |
| | Evolution of black yeasts: possible adaptation to the human host | Q40789772 |
| | Posaconazole therapy of disseminated phaeohyphomycosis in a murine model | Q40882553 |
| | Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 |
| | Cell-mediated immune responses in mice infected with fonsecaea pedrosoi | Q41110797 |
| | Molecular epidemiology of Fonsecaea pedrosoi using mitochondrial DNA analysis | Q41480725 |
| | Inhibitory effect of melanin on the interaction of Fonsecaea pedrosoi with mammalian cells in vitro | Q41648229 |
| | Selective factors involved in oil flotation isolation of black yeasts from the environment | Q41810587 |
| | Antifungal therapy in an athymic murine model of chromoblastomycosis by Fonsecaea pedrosoi | Q41906983 |
| | Infection of HIV-specific CD4 T helper cells and the clonal composition of the response | Q41982002 |
| | Exophiala spinifera and its allies: diagnostics from morphology to DNA barcoding | Q33327704 |
| | Concurrent double infections of the skin: phaeohyphomycosis and nocardiosis in a patient with idiopathic thrombocytopenic purpura | Q33368937 |
| | Successful treatment of chromoblastomycosis of 36 years duration caused by Fonsecaea monophora | Q33458499 |
| | The clinical spectrum of Exophiala jeanselmei, with a case report and in vitro antifungal susceptibility of the species | Q33488584 |
| | Fonsecaea monophora cerebral phaeohyphomycosis: case report of successful surgical excision and voriconazole treatment and review | Q33526435 |
| | The role of dendritic cells in the induction and regulation of immunity to microbial infection. | Q33711401 |
| | Expression of a constitutively active Cdc42 homologue promotes development of sclerotic bodies but represses hyphal growth in the zoopathogenic fungus Wangiella (Exophiala) dermatitidis | Q33791573 |
| | Black fungi: clinical and pathogenic approaches | Q33934742 |
| | Chromoblastomycosis: clinical and mycologic experience of 51 cases | Q33950643 |
| | Detection and identification of fungal pathogens by PCR and by ITS2 and 5.8S ribosomal DNA typing in ocular infections | Q33973144 |
| | Cell wall maintenance in fungi | Q33987694 |
| | Humoral immune response in chromoblastomycosis during and after therapy | Q33998421 |
| | Type 1/Type 2 immunity in infectious diseases | Q34105379 |
| | Molecular genetic studies of the model dematiaceous pathogen Wangiella dermatitidis | Q34160923 |
| | Waterborne Exophiala species causing disease in cold-blooded animals | Q34189208 |
| | Melanin from Fonsecaea pedrosoi induces production of human antifungal antibodies and enhances the antimicrobial efficacy of phagocytes. | Q34285375 |
| | Primary central nervous system phaeohyphomycosis: a review of 101 cases | Q34286912 |
| | In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature | Q34317476 |
| | Genetic susceptibility to Candida infections | Q34341908 |
| | Clinical and mycological spectra of Wangiella dermatitidis infections | Q34346626 |
| | Adjunctive immune therapy for fungal infections | Q34350401 |
| | Structure, cellular distribution, antigenicity, and biological functions of Fonsecaea pedrosoi ceramide monohexosides | Q34469047 |
| | Fungi growing on aromatic hydrocarbons: biotechnology's unexpected encounter with biohazard? | Q34488480 |
| | Spectrum of clinically relevant Exophiala species in the United States | Q34642468 |
| | High rate of Exophiala dermatitidis recovery in the airways of patients with cystic fibrosis is associated with pancreatic insufficiency | Q34741388 |
| | Subcutaneous phaeohyphomycosis caused by Veronaea botryosa in the People's Republic of China. | Q34991607 |
| | Restoration of pattern recognition receptor costimulation to treat chromoblastomycosis, a chronic fungal infection of the skin | Q34995688 |
| | Biosynthesis of fungal melanins and their importance for human pathogenic fungi | Q35079260 |
| | The contribution of melanin to microbial pathogenesis | Q35098810 |
| | Impact of melanin on microbial virulence and clinical resistance to antimicrobial compounds | Q35127872 |
| | An unusual dematiaceous fungal infection of the skin caused by Fonsecaea pedrosoi: a case report and review of the literature | Q35129865 |
| | Fungal diseases of fish | Q35167099 |
| | Therapeutic approaches to subcutaneous mycoses | Q35178530 |
| | Mucormycosis in systemic lupus erythematosus | Q35588087 |
| | Treating chromoblastomycosis with systemic antifungals | Q35680574 |
| | Immunotherapy for invasive fungal infections: from bench to bedside | Q35741471 |
| | Subcutaneous fungal infections | Q35967449 |
| | Interactions of Toll-like receptors with fungi | Q35982256 |
| | Successful therapy of cerebral phaeohyphomycosis due to Ramichloridium mackenziei with the new triazole posaconazole | Q36042838 |
| | WdStuAp, an APSES transcription factor, is a regulator of yeast-hyphal transitions in Wangiella (Exophiala) dermatitidis | Q36095268 |
| | Phaeohyphomycosis in Korea. | Q36111876 |
| | Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens | Q36355614 |
| | Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells | Q36368860 |
| | Management of chromoblastomycosis: novel perspectives | Q36412372 |
| | Sarcinomyces phaeomuriformis: a new dematiaceous hyphomycete | Q36480786 |
| | Current understandings on the immunology of leishmaniasis and recent developments in prevention and treatment | Q36538890 |
| | Catheter-associated fungemia due to Exophiala oligosperma in a leukemic child and review of fungemia cases caused by Exophiala species | Q36620476 |
| | The role of the beta-glucan receptor Dectin-1 in control of fungal infection | Q36809539 |
| | Diseases of amphibians | Q36860364 |
| | Biology and pathogenesis of Fonsecaea pedrosoi, the major etiologic agent of chromoblastomycosis | Q36889096 |
| | DNA and the classical way: identification of medically important molds in the 21st century. | Q36915214 |
| | New biosynthetic step in the melanin pathway of Wangiella (Exophiala) dermatitidis: evidence for 2-acetyl-1,3,6,8-Tetrahydroxynaphthalene as a novel precursor | Q36939039 |
| | The cell wall: a carbohydrate armour for the fungal cell | Q36940056 |
| | Immunoaffinity purification of the class V chitin synthase of Wangiella (Exophiala) dermatitidis | Q37306477 |
| | Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment | Q37351604 |
| | Chromoblastomycosis: clinical presentation and management | Q37540304 |
| | Th17 responses and host defense against microorganisms: an overview | Q37665895 |
| | T-cell Subsets and Antifungal Host Defenses | Q37803134 |
| | Melanin as a virulence factor in pathogenic fungi | Q38016407 |
| | Training innate immunity: the changing concept of immunological memory in innate host defence | Q38122699 |
| | Efficacy of caspofungin and posaconazole in a murine model of disseminated Exophiala infection. | Q38504361 |
| | Exophiala jeanselmei var. lecanii-corni, an aetiologic agent of human phaeohyphomycosis, with report of a case | Q38572109 |
| | Hyalohyphomycosis and phaeohyphomycosis: two global disease entities of public health importance | Q38593633 |
| | Inhibition of nitric oxide production by macrophages in chromoblastomycosis: a role for Fonsecaea pedrosoi melanin | Q38912585 |
| | Cytokines and lymphocyte proliferation in patients with different clinical forms of chromoblastomycosis | Q39229362 |
| | Melanin in a meristematic mutant of Fonsecaea monophora inhibits the production of nitric oxide and Th1 cytokines of murine macrophages | Q39262084 |
| | Antigen distribution and antigen-presenting cells in skin biopsies of human chromoblastomycosis | Q39480075 |
| | Exophiala sideris, a novel black yeast isolated from environments polluted with toxic alkyl benzenes and arsenic | Q46835787 |
| | The cell-mediated immune reaction in the cutaneous lesion of chromoblastomycosis and their correlation with different clinical forms of the disease | Q47930674 |
| | Cerebral phaeohyphomycosis caused by ladophialophora bantiana and Fonsecaea monophora: report of three cases | Q48277676 |
| | Subcutaneous phaeohyphomycosis in immunocompetent patients: two new cases caused by Exophiala jeanselmei and Cladophialophora carrionii. | Q48439675 |
| | Cerebral phaeohyphomycosis due to Cladophialophora bantiana in a Huacaya alpaca (Vicugna pacos). | Q50539377 |
| | Chromoblastomycosis and phaeohyphomycosis: new concepts, diagnosis, and mycology. | Q50715374 |
| | Delayed-type hypersensitivity response to crude and fractionated antigens from Fonsecaea pedrosoi CMMI 1 grown in different culture media. | Q51166405 |
| | Subcutaneous phaeohyphomycosis caused by Exophiala equina, with susceptibility to eight antifungal drugs. | Q51269860 |
| | Analyses of phagocytosis, evoked oxidative burst, and killing of black yeasts by human neutrophils: a tool for estimating their pathogenicity? | Q51682950 |
| | Monocyte-derived dendritic cells from patients with severe forms of chromoblastomycosis induce CD4+ T cell activation in vitro. | Q51827105 |
| | Calcium regulates in vitro dimorphism in chromoblastomycotic fungi. | Q54045212 |
| | Nosocomial Outbreak ofExophiala jeanselmeiFungemia Associated with Contamination of Hospital Water | Q56970574 |
| | Immunity to fungal infections | Q58855371 |
| | Dectin-1 promotes fungicidal activity of human neutrophils | Q59945061 |
| | Lethargic crab disease: multidisciplinary evidence supports a mycotic etiology | Q60442094 |
| | Phagocytosis ofFonsecaea pedrosoiconidia, but not sclerotic cells caused by Langerhans cells, inhibits CD40 and B7-2 expression | Q62032305 |
| | IL-4 Is a Mediator of IL-12p70 Induction by Human Th2 Cells: Reversal of Polarized Th2 Phenotype by Dendritic Cells | Q62589132 |
| | Partial suppression of cell mediated immunity in chromoblastomycosis | Q67582628 |
| | Long-term fungal cultures from sputum of patients with cystic fibrosis | Q67893862 |
| | Melanized and non-melanized multicellular form mutants of Wangiella dermatitidis in mice: mortality and histopathology studies | Q67910402 |
| | No granules, no mycetomas | Q69544558 |
| | Experimental murine chromomycosis mimicking chronic progressive human disease | Q69646524 |
| | Phaeohyphomycosis caused by Exophiala moniliae | Q70789980 |
| | Curvularia lunata in experimental phaeohyphomycosis | Q70919644 |
| | The in vitro susceptibility of Fonsecaea pedrosoi to activated macrophages | Q72139459 |
| | Nutritional physiology and selective isolation of Exophiala dermatitidis | Q72688879 |
| | Sarcinomyces petricola, a new microcolonial fungus from marble in the Mediterranean basin | Q73250536 |
| | Mitochondrial DNA analysis of Exophiala jeanselmei var. lecanii-corni and Exophiala castellanii | Q73816680 |
| | Temperature and NaCl-tolerance of rock-inhabiting meristematic fungi | Q74613682 |
| | Exophiala (Wangiella) dermatitidis keratitis after keratoplasty | Q77317057 |
| | Antifungal immunity and adjuvant cytokine immune enhancement in cancer patients with invasive fungal infections | Q79446828 |
| | Posaconazole treatment of refractory eumycetoma and chromoblastomycosis | Q82910521 |
| | Effect of herbal melanin on IL-8: a possible role of Toll-like receptor 4 (TLR4) | Q83226590 |
| | Immunotherapy for fungal infections | Q84775762 |
| | Mucormycosis and chromoblastomycosis occurring in a patient with leprosy type 2 reaction under prolonged corticosteroid and thalidomide therapy | Q87417471 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pathogenesis | Q372016 |
| P1104 | number of pages | 16 | |
| P304 | page(s) | 527-542 | |
| P577 | publication date | 2014-07-01 | |
| P1433 | published in | Clinical Microbiology Reviews | Q5133777 |
| P1476 | title | Black yeasts and their filamentous relatives: principles of pathogenesis and host defense | |
| P478 | volume | 27 | |